First head-to-head study comparing rosuvastatin and atorvastatin effects on the treatment of atherosclerosis.
D000924:Anticholesteremic Agents / Q000008:administration & dosage; D050197:Atherosclerosis / Q000150:complications / Q000188:drug therapy*; D000069059:Atorvastatin; D002985:Clinical Protocols; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000188:drug therapy* / Q000209:etiology; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005464:Fluorobenzenes / Q000008:administration & dosage*; D006538:Heptanoic Acids / Q000008:administration & dosage*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage; D050356:Lipid Metabolism / Q000187:drug effects*; D011743:Pyrimidines / Q000008:administration & dosage*; D011758:Pyrroles / Q000008:administration & dosage*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000008:administration & dosage*; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D005464:Fluorobenzenes; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D011758:Pyrroles; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D000069059:Atorvastatin